Anti E. coli Activity of Herbal Medicines: a Review
Abstract
Escherichia coli is the gram negative bacilli of Entrobacteriaceae family that commonly found in intestinal infections and many infections outside the intestine, like urinary tract infections (UTI), cholecystitis, wound infections, meningitis, septicemia, pulmonary infections, and many more. Plants are rich sources of bioactive compounds, hence they can be effective in a wide variety of diseases. The pandemic spread of multidrug-resistant (MDR) bacteria (i.e., extended-spectrum b-lactamase-producing Enterobacteriaceae (ESBLPE), Carbapenemase-producing Enterobacteriaceae (CPE)) threaten healthcare Worldwide. The present review is a report of the most effective medicinal plants against E. coli. In this research, the required online database searches were conducted using the key words such as bacteria, E. coli and medicinal plants. Databases of Web of Science, PubMed, Scopus, Google Scholar, and ScienceDirect were explored to find and explore related articles. Since the incidence of E. coli is high, the aim of this study is to identify and report anti E. coli medicinal plants in Iran. The obtained results showed that there were 51 medicinal herbs that could be considered as the main medicinal plants capable of affecting E. coli.References
Tadesse DA, Zhao S, Tong E, Ayers S, Singh A, Bartholomew MJ, et al. Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950–2002. Emerging infectious diseases. 2012;18(5):741.
Von Baum H, Marre R. Antimicrobial resistance of Escherichia coli and therapeutic implications. International Journal of Medical Microbiology. 2005;295(6):503-11.
Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nature Reviews Microbiology. 2010;8(1):26-38.
Javaloyas M, Garcia-Somoza D, Gudiol F. Epidemiology and prognosis of bacteremia: a 10-y study in a community hospital. Scandinavian journal of infectious diseases. 2002;34(6):436-41.
Pedersen G, Schønheyder H, Kristensen B, Sørensen H. Community-acquired bacteraemia and antibiotic resistance. Trends during a 17-year period in a Danish county. Danish medical bulletin. 2000;47(4):296-300.
Pedersen G, Schønheyder H, Sørensen H. Source of infection and other factors associated with case fatality in community‐acquired bacteremia—a Danish population‐based cohort study from 1992 to 1997. Clinical microbiology and infection. 2003;9(8):793-802.
Gosbell I, Newton P, Sullivan E. Survey of blood cultures from five community hospitals in south‐western Sydney, Australia, 1993–1994. Internal Medicine Journal. 1999;29(5):684-92.
Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR, Sauver JLS, Wilson WR, et al. Age-and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Archives of internal medicine. 2007;167(8):834-9.
Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clinical Infectious Diseases. 1997;24(4):584-602.
Goto M, Al‐Hasan M. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clinical Microbiology and Infection. 2013;19(6):501-9.
Diekema D, Beekmann S, Chapin K, Morel K, Munson E, Doern G. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. Journal of Clinical Microbiology. 2003;41(8):3655-60.
Takeshita N, Kawamura I, Kurai H, Araoka H, Yoneyama A, Fujita T, et al. Unique characteristics of community-onset healthcare-associated bloodstream infections: a multi-centre prospective surveillance study of bloodstream infections in Japan. Journal of Hospital Infection. 2017;96(1):29-34.
Peralta G, Sanchez MB, Garrido JC, De Benito I, Cano ME, Martínez-Martínez L, et al. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. Journal of antimicrobial chemotherapy. 2007;60(4):855-63.
Ben-Ami R, Rodríguez-Baño J, Arslan H, Pitout JD, Quentin C, Calbo ES, et al. A multinational survey of risk factors for infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clinical Infectious Diseases. 2009;49(5):682-90.
Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, et al. Community infections caused by extended-spectrum β-lactamase–producing Escherichia coli. Archives of internal medicine. 2008;168(17):1897-902.
Rodríguez-Baño J, Alcalá J, Cisneros JM, Grill F, Oliver A, Horcajada JP, et al. Escherichia coli producing SHV-type extended-spectrum β-lactamase is a significant cause of community-acquired infection. Journal of antimicrobial chemotherapy. 2009;63(4):781-4.
Tumbarello M, Sali M, Trecarichi EM, Leone F, Rossi M, Fiori B, et al. Bloodstream infections caused by extended-spectrum-β-lactamase-producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrobial agents and chemotherapy. 2008;52(9):3244-52.
Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase–producing Enterobacteriaceae: variability by site of infection. Archives of internal medicine. 2005;165(12):1375-80.
Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clinical Infectious Diseases. 2001;32(8):1162-71.
Lee SY, Kotapati S, Kuti JL, Nightingale CH, Nicolau DP. Impact of extended-spectrum β-lactamase–producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infection Control & Hospital Epidemiology. 2006;27(11):1226-32.
Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrobial agents and chemotherapy. 2006;50(4):1257-62.
Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy. 2007;60(5):913-20.
Gray J. Epidemiology of Escherichia coli bloodstream infections in children. Journal of Hospital Infection. 2017;95(4):383-4.
Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clinical microbiology reviews. 2005;18(4):657-86.
Ortega M, Marco F, Soriano A, Almela M, Martínez J, Munoz A, et al. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. Journal of antimicrobial chemotherapy. 2009;63(3):568-74.
Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Cisneros JM, Peña C, et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-β-lactamase-producing Escherichia coli. Journal of clinical microbiology. 2010;48(5):1726-31.
Bag A, Chattopadhyay RR. Synergistic antibiofilm efficacy of a gallotannin 1, 2, 6-tri-O-galloyl-β-D-glucopyranose from Terminalia chebula fruit in combination with gentamicin and trimethoprim against multidrug resistant uropathogenic Escherichia coli biofilms. PloS one. 2017;12(5):e0178712.
Darabpour E, Bavi AP, Motamedi H, Nejad SMS. Antibacterial activity of different parts of Peganum harmala L. growing in Iran against multi-drug resistant bacteria. EXCLI J. 2011;10:252-63.
Zuo G-Y, Zhang X-J, Yang C-X, Han J, Wang G-C, Bian Z-Q. Evaluation of traditional Chinese medicinal plants for anti-MRSA activity with reference to the treatment record of infectious diseases. Molecules. 2012;17(3):2955-67.
Adetutu A, Morgan WA, Corcoran O, Chimezie F. Antibacterial activity and in vitro cytotoxicity of extracts and fractions of Parkia biglobosa (Jacq.) Benth. stem bark and Ageratum conyzoides Linn. leaves. Environmental toxicology and pharmacology. 2012;34(2):478-83.
Zonyane S, Van Vuuren S, Makunga N. Antimicrobial interactions of Khoi-San poly-herbal remedies with emphasis on the combination; Agathosma crenulata, Dodonaea viscosa and Eucalyptus globulus. Journal of ethnopharmacology. 2013;148(1):144-51.
WHO. Traditional medicine, WHO, 2010. 2010.
Bunsupa S, Yamazaki M, Saito K. Quinolizidine alkaloid biosynthesis: recent advances and future prospects. Frontiers in plant science. 2012;3.
Raut JS, Karuppayil SM. A status review on the medicinal properties of essential oils. Industrial Crops and Products. 2014;62:250-64.
Alizadeh A, Abdollahzadeh H. Essential oil constituents and antimicrobial activity of Pycnocycla bashagardiana Mozaff. from Iran. Natural product research. 2017:1-4.
Bonjar GS. Antibacterial screening of plants used in Iranian folkloric medicine. Fitoterapia. 2004;75(2):231-5.
Ebrahimabadi AH, Ebrahimabadi EH, Djafari-Bidgoli Z, Kashi FJ, Mazoochi A, Batooli H. Composition and antioxidant and antimicrobial activity of the essential oil and extracts of Stachys inflata Benth from Iran. Food Chemistry. 2010;119(2):452-8.
Pirbalouti AG, Malekpoor F, Enteshari S, Yousefi M, Momtaz H, Hamedi B. Antibacterial activity of some folklore medicinal plants used by Bakhtiari tribal in Southwest Iran. International Journal of Biology. 2010;2(2):55.
Bazzaz B, Haririzadeh G. Screening of Iranian plants for antimicrobial activity. Pharmaceutical Biology. 2003;41(8):573-83.
Bonjar S. Evaluation of antibacterial properties of some medicinal plants used in Iran. Journal of ethnopharmacology. 2004;94(2):301-5.
Fazeli MR, Amin G, Attari MMA, Ashtiani H, Jamalifar H, Samadi N. Antimicrobial activities of Iranian sumac and avishan-e shirazi (Zataria multiflora) against some food-borne bacteria. Food control. 2007;18(6):646-9.
Jaberian H, Piri K, Nazari J. Phytochemical composition and in vitro antimicrobial and antioxidant activities of some medicinal plants. Food chemistry. 2013;136(1):237-44.
Saei-Dehkordi SS, Tajik H, Moradi M, Khalighi-Sigaroodi F. Chemical composition of essential oils in Zataria multiflora Boiss. from different parts of Iran and their radical scavenging and antimicrobial activity. Food and Chemical Toxicology. 2010;48(6):1562-7.
Khosravi A, Behzadi A. Evaluation of the antibacterial activity of the seed hull of Quercusbrantii on some gram negative bacteria. Pak J Med Sci. 2006;22(4):429-32.
Behmanesh B, Heshmati G, Mazandarani M, Rezaei M, Ahmadi A, Ghaemi E, et al. Chemical composition and antibacterial activity from essential oil of Artemisia sieberi Besser subsp. Sieberi in North of Iran. Asian Journal of Plant Sciences. 2007;6(3):562-4.
Darabpour E, Motamedi H, Poshtkouhian Bavi A, Nejad S, Mansour S. Antibacterial activity of different parts of Peganum harmala L. growing in Iran against multi-drug resistant bacteria. 2011.
Saidi M, Sadeghifard N, Kazemian H, Sekawi Z, Badakhsh B, Friadian S, et al. Ex Vivo Evaluation of Thymus daenensis as an Antioxidant and Antibacterial Medicinal Herb. Drug Research. 2016;66(12):657-9.
Mahmoudzadeh M, Hosseini H, Nasrollahzadeh J, Khaneghah AM, Rismanchi M, Chaves RD, et al. Antibacterial Activity of Carum copticum Essential Oil Against Escherichia Coli O157:H7 in Meat: Stx Genes Expression. Current microbiology. 2016;73(2):265-72.
Faezeh F, Salome D, Abolfazl D, Reza ZM. Considering the antibacterial activity of Zataria multiflora Boiss essential oil treated with gamma-irradiation in vitro and in vivo systems. Radiation Physics and Chemistry. 2015;106:145-50.
Shahidi Bonjar G, Aghighi S, Karimi Nik A. Antibacterial and antifungal survey in plants used in indigenous herbal-medicine of south east regions of Iran. Journal of Biological Sciences. 2004;4(3):405-12.
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation. Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This work is licensed under a Creative Commons license (CC-BY). However, the license permits any user to read, copy, redistribute and and make derivative the material in any medium or format for any purpose, even commercially.
